Grant Funding Opportunities: 12/5/2014
Weekly Grant Funding Opportunities
Please feel free to send special funding search requests any time (susan_craft@ncbiotech.org). Grant funding requests are included our regular research and include a fee of $100/hour. Also, let us know if any of your partners have submitted grant applications to funding announcements posted in the weekly grant alert emails. We would love to hear of their successes!
Visit NCBiotech’s Funding Gateway page to get more information on funding announcements, links to opportunity search databases and grant development tips.
Announcements
The Defense Advanced Research Projects Agency (DARPA) has simplified its Broad Agency Announcement (BAA) proposal process to better attract and fund new ideas in biotechnology.
This new Biotechnology EZ BAA, overseen by DARPA’s Biological Technologies Office (BTO), provides the opportunity for innovators to receive seed funding of up to $700,000 simply by submitting an initial two-page white paper describing their ideas.
Unlike traditional BAAs, which specify topics and minimum performance requirements, the EZ BAA is open to any idea with the potential to yield revolutionary new capabilities in the biotech. This eliminates the need for proposers to search or wait for specific opportunities relevant to their expertise.
BAAs also typically run 40 to 60 pages and requires highly structured responses from proposers. Under the simplified EZ BAA, DARPA managers will review the 2-page white papers within just a few weeks of submission, and either encourage or discourage submission of a full proposal of no more than 20 pages.
Upcoming Deadlines
Deadline: 1/1/2015
Agency: Glaucoma Foundation
Program: Grant Research Progra
Description: The Glaucoma Foundation offers grants to researchers striving to improve the lives of glaucoma patients through novel innovations and scientific advances. In 2015, the area of focus for the foundation's Grant Research program is exfoliation syndrome and exfoliation glaucoma. Initial grant funding for a one-year period will range up to $40,000, and grantees are permitted to apply for a grant renewal of up to $50,000. Renewal grants are awarded for a period of one year based on the promise of the findings generated by the initial research.
Award Amount: $ 40,000
Website: www.glaucomafoundation.org/Grant_Application.htm
Eligibility: To be eligible, applicants must be an M.D working in the area of glaucoma research.
Deadline: 1/5/2015
Agency: National Science Foundation
Program: Industry/University Cooperative Research Centers Program
Description: The Industry/University Cooperative Research Centers (I/UCRC) program develops long-term partnerships among industry, academe, and government. The centers are catalyzed by a small investment from the National Science Foundation (NSF) and are primarily supported by industry center members, with NSF taking a supporting role in the development and evolution of the center. Each center is established to conduct research that is of interest to both the industry members and the center faculty. An I/UCRC contributes to the nation's research infrastructure base and enhances the intellectual capacity of the engineering and science workforce through the integration of research and education. As appropriate, an I/UCRC uses international collaborations to advance these goals within the global context.
Award Amount: $10,000-200,000
Website: www.nsf.gov/pubs/2013/nsf13594/nsf13594.htm
Eligibility: Only U.S. academic institutions with graduate research programs may apply.
New Opportunities
Deadline: 1/12/2015
Agency: National Institutes of Health
Program: Biomarkers of Alzheimers Disease in Down Syndrome (R01)
Description: The goal of this funding opportunity announcement is to enable the identification of the longitudinal progression of Alzheimer's disease in adults with Down Syndrome using clinical, cognitive, imaging, genetic and biochemical biomarkers.
Award Amount: $2,500,000
Website: www.grants.gov/web/grants/view-opportunity.html?oppId=263416
Eligibility: State, county or city governments; public and private institutes of higher education; school districts; small businesses; nonprofits; Native American tribal organizations; others
Deadline: 1/14/2014
Agency: National Institutes of Health
Program: (Re)Building a Kidney: Cells to Organ (UH2/UH3)
Description: This Funding Opportunity Announcement (FOA) invites new research project applications to participate in the NIDDK (Re)Building a Kidney Consortium. The projects will be part of a research network focused on the expansion of tools, resources, and knowledge that will guide studies on the in vivo regeneration of functional nephrons or in vitro generation of nephrons for kidney transplant. Funds will be made available through the UH2/UH3 cooperative agreement award mechanism. The initial UH2 phase will support milestone-driven projects that will inform strategies for the enhancement of endogenous regenerative repair processes and generation of cell types important for the development of functional nephrons. UH2 projects that have met their scientific milestones will be eligible for transition to the second UH3 phase after NIH administrative review. The UH3 award is to provide a second phase for the support for innovative exploratory and development research activities initiated under the UH2 mechanism. UH3 phase will support milestone-driven projects. It is anticipated that relevant projects will be integrated as appropriate to further synergistic interactions and collaborations.
Award Amount: Varies
Website: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-14-010.html
Eligibility: State, county or city governments; public and private institutes of higher education; school districts; small businesses; nonprofits; Native American tribal organizations; others
Deadline: 1/20/2014
Agency: National Institutes of Health
Program: Stem Cell-Derived Blood Products for Therapeutic Use: Technology Improvement (R43/R44)
Description: The primary objective of this funding opportunity announcement is to support the development of improved techniques and tools to enhance the production of clinically-relevant, functional stem cell-derived red blood cells or platelets in a more efficient and cost-effective manner. The research supported will develop and enhance technologies that enable the production of functional stem cell-based therapies with potential commercial and clinical viability.
Award Amount: Varies
Website: SBIR: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-15-030.html
STTR: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-15-029.html
Eligibility: Small businesses
Deadline: Rolling
Agency: North Carolina Biotechnology Center
Program: Technology Enhancement Grants
Description: The Technology Enhancement Grant (TEG) Program provides non-repayable grant funding to North Carolina universities or other NC research institutions through their respective technology transfer offices. Under this program, awards of up to $50,000 are available to fund a commercially-focused research study to enhance the university’s licensing position for a commercially promising technology. The proposed project will ideally incorporate study endpoints designed to directly address milestones defined by potential licensees.
Award Amount: $50,000
Eligibility: Proposals to the TEG program must:
Be submitted by a technology transfer officer or other representative with licensing authority on behalf of a North Carolina university or not-for-profit research institution.
Pertain to a proprietary life sciences technology.
Demonstrate that protection of licensable intellectual property (IP) has been initiated.
Demonstrate that a dialog with an independent potential licensee of the technology has been initiated.
Attest that the IP rights are assigned to the applicant’s institution and have not been committed through license, option or letter-of-intent to license to any third-party at the time of application.